Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani; Kerri-Marie Heenan; Denise McKeegan; Nazia Chaudhuri

doi:10.1016/j.iac.2023.01.004

Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani, Kerri-Marie Heenan, Denise McKeegan, Nazia Chaudhuri

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

10 Downloads (Pure)

Abstract

The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

Original language	English
Pages (from-to)	389-410
Number of pages	22
Journal	Immunology and allergy clinics of North America
Volume	43
Issue number	2
Early online date	3 Mar 2023
DOIs	https://doi.org/10.1016/j.iac.2023.01.004
Publication status	Published (in print/issue) - 31 May 2023

Bibliographical note

Funding Information:
N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.

Keywords

Humans
COVID-19
Post-Acute COVID-19 Syndrome
Respiration Disorders
Lung Diseases, Interstitial - diagnosis - epidemiology - etiology
SARS-CoV-2
Interstitial lung disease
Long-term impact
Post-COVID fibrosis
Post-COVID-19 condition (long COVID)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.iac.2023.01.004

CH0002_Chaudhuri_v3_cleanAuthor Accepted Manuscript, 380 KB

Cite this

@article{b24d44c997944970a9e364eefcf3a2e8,

title = "Post-COVID Interstitial Lung Disease-The Tip of the Iceberg",

abstract = "The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright {\textcopyright} 2023 Elsevier Inc. All rights reserved.]",

keywords = "Humans, COVID-19, Post-Acute COVID-19 Syndrome, Respiration Disorders, Lung Diseases, Interstitial - diagnosis - epidemiology - etiology, SARS-CoV-2, Interstitial lung disease, Long-term impact, Post-COVID fibrosis, Post-COVID-19 condition (long COVID)",

author = "Namrata Kewalramani and Kerri-Marie Heenan and Denise McKeegan and Nazia Chaudhuri",

note = "Funding Information: N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.",

year = "2023",

month = may,

day = "31",

doi = "10.1016/j.iac.2023.01.004",

language = "English",

volume = "43",

pages = "389--410",

journal = "Immunology and allergy clinics of North America",

issn = "1557-8607",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

AU - Kewalramani, Namrata

AU - Heenan, Kerri-Marie

AU - McKeegan, Denise

AU - Chaudhuri, Nazia

N1 - Funding Information: N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.

PY - 2023/5/31

Y1 - 2023/5/31

N2 - The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

AB - The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

KW - Humans

KW - COVID-19

KW - Post-Acute COVID-19 Syndrome

KW - Respiration Disorders

KW - Lung Diseases, Interstitial - diagnosis - epidemiology - etiology

KW - SARS-CoV-2

KW - Interstitial lung disease

KW - Long-term impact

KW - Post-COVID fibrosis

KW - Post-COVID-19 condition (long COVID)

UR - http://www.scopus.com/inward/record.url?scp=85149644086&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2023.01.004

DO - 10.1016/j.iac.2023.01.004

M3 - Article

C2 - 37055095

SN - 1557-8607

VL - 43

SP - 389

EP - 410

JO - Immunology and allergy clinics of North America

JF - Immunology and allergy clinics of North America

IS - 2

ER -

Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this